Mumbai, India has emerged as a significant hub for the production of Acalabrutinib Active Pharmaceutical Ingredient (API), with several companies focused on its creation . Notably, a few manufacturers in this region are recognized for their high-quality Acalabrutinib (CAS 1420477-60-6) production